Metraipolis › archive › dc_628f697b117e

Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World… — Europe PMC PMID:41925338

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41925338
DOI: 10.1155/jdr/8464330
License (as archived): solo-consultazione
Archived: 2026-11-07T05:33:01.649Z
SHA-256 of the archived text: 143f128fd1c0d5041aca75a0c14b29f4ce26558fe36a864ae2e24f79880fb32a
Stable URL of this page: https://metraipolis.com/documento/dc_628f697b117e

How to cite

Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World… — Europe PMC PMID:41925338 — Europe PMC (en), https://europepmc.org/article/MED/41925338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_628f697b117e (Metraipolis archive dc_628f697b117e, sha256 143f128fd1c0d5041aca75a0c14b29f4ce26558fe36a864ae2e24f79880fb32a)

BibTeX

@misc{dc628f697b117e,
  title = {Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World… — Europe PMC PMID:41925338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41925338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_628f697b117e; sha256 143f128fd1c0d5041aca75a0c14b29f4ce26558fe36a864ae2e24f79880fb32a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41925338. Agents can read the archived copy with the MCP tool read_document.